FDA Releases Draft Guidance on Certifications for Drug, Biological Product, and Device Applications

Summary

The FDA is announcing a draft guidance that outlines the agency's views on certain information and documents submitted to FDA, clarifying the need for certifications to accompany drug, biological product, and device applications, in compliance with Section 402(j) of the Public Health Service Act.